Publication Name	World Journal of Clinical Pediatrics
Manuscript ID	21251
Country	South Korea

Received	2015-07-02 08:30
Peer-Review Started	2015-07-08 13:51
First Decision by Editorial Office Director
Return for Revision	2015-08-25 17:37
Revised	2015-08-28 20:54
Publication Fee Transferred
Second Decision by Editor	2015-10-08 12:25
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2015-10-19 15:36
Articles in Press	2015-10-19 15:36
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-21 19:56
Publish the Manuscript Online	2015-11-10 12:29

ISSN	2219-2808 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pediatrics
Manuscript Type	Minireviews
Article Title	Use of corticosteroids during acute phase of Kawasaki disease
Manuscript Source	Invited Manuscript
All Author List	Jeong Jin Yu
Funding Agency and Grant Number
Corresponding Author	Jeong Jin Yu, MD, PhD, Department of Pediatrics, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea. pediatrist@medimail.co.kr
Key Words	Kawasaki disease; Methylprednisolone; Corticosteroids; Coronary aneurysm; Immunoglobulins; Prednisolone; Fever
Core Tip	In spite of initial intravenous immunoglobulin (IVIG) treatment, a significant number of patients are unresponsive to it and are at a higher risk for coronary artery lesions. Corticosteroids have been used as a secondary drug or used in combination with IVIG. There are several options of using corticosteroids for the treatment of patients with Kawasaki disease during the acute phase. A thorough review of the use of corticosteroids in acute phase Kawasaki disease was performed in this paper.
Publish Date	2015-11-10 12:29
Citation	Yu JJ. Use of corticosteroids during acute phase of Kawasaki disease. World J Clin Pediatr 2015; 4(4): 135-142
URL	http://www.wjgnet.com/2219-2808/full/v4/i4/135.htm
DOI	http://dx.doi.org/10.5409/wjcp.v4.i4.135

Full Article (PDF)	WJCP-4-135.pdf
Full Article (Word)	WJCP-4-135.doc
Manuscript File	21251-Review.docx
Answering Reviewers	21251-Answering reviewers.pdf
Audio Core Tip	21251-Audio core tip.wma
Conflict-of-Interest Disclosure Form	21251-Conflict-of-interest statement.pdf
Copyright License Agreement	21251-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	21251-Language certificate.pdf
Peer-review Report	21251-Peer-review(s).pdf
Scientific Misconduct Check	21251-Scientific misconduct check.pdf
Scientific Editor Work List	21251-Scientific editor work list.pdf